Latest News about VTRS
Recent news which mentions VTRS
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
November 01, 2024
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday?
September 24, 2024
From Benzinga
EXCLUSIVE: Options Expert Warns Of 'Terrible Week' After Friday's Triple Witching
September 20, 2024
From Benzinga
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
September 06, 2024
From Benzinga
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
September 06, 2024
From Benzinga
3 Top Value Stocks to Buy Right Now
August 20, 2024
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
From Benzinga
US Drugmaker Viatris Q2 Earnings Edge Out Analysts Expectation On Strong Demand For Branded And Generic Drugs
August 08, 2024
From Benzinga
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
August 06, 2024
From Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
July 26, 2024
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Tickers
VTRS
From InvestorPlace
BTIG Research Predicts Over 118% Rally for These 3 Stocks
April 15, 2024
From InvestorPlace
From InvestorPlace
Is Viatris a Great Dividend Stock or Just a Value Trap?
March 14, 2024
Tickers
VTRS
From Motley Fool
2 Dirt Cheap Dividend Stocks to Buy and Hold
March 11, 2024
From Motley Fool
Stocks Fall Ahead Of Fed's Inflation Data, UnitedHealth Sinks, Bitcoin Tops $61,000: What's Driving Markets Wednesday?
February 28, 2024
From Benzinga
Earnings Scheduled For February 28, 2024
February 28, 2024
From Benzinga
Viatris And Idorsia Forge Global Partnership For Breakthrough Heart Attack Treatments
February 28, 2024
From Benzinga
3 Overextended Stocks That Need to Slash Their Dividends ASAP
February 27, 2024
From InvestorPlace
3 Bargain Stocks to Snatch Up Before They Bounce Back
February 26, 2024
From InvestorPlace
5 Value Stocks In The Healthcare Sector
February 26, 2024
From Benzinga
Regeneron Pharma's Pipeline Makes This Analyst Turn Bullish
January 12, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.